ArticleBreast cancer (Tokyo, Japan)2026

Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study.

Masanori Oshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.